Medical

signal of a serious risk

Information related to a serious adverse drug experience derived from:
(1) A clinical trial;
(2) Adverse event reports under subsection (K) (1);
(3) Routine active surveillance under subsection (K) (3);
(4) A postapproval studies including a study under paragraph (4) (B); or
(5) Peer-reviewed biomedical literature.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.